寻求阿片类药物脱毒治疗者使用苯二氮䓬类药物的原因。
Reasons for Benzodiazepine Use Among Persons Seeking Opioid Detoxification.
作者信息
Stein Michael D, Kanabar Mitika, Anderson Bradley J, Lembke Anna, Bailey Genie L
机构信息
Behavioral Medicine Division, Butler Hospital, Providence, RI, 02906, USA; Warren Alpert Medical School of Brown University, Providence, RI, 02912, USA.
Stanford University School of Medicine, Stanford, CA, 94305, USA.
出版信息
J Subst Abuse Treat. 2016 Sep;68:57-61. doi: 10.1016/j.jsat.2016.06.008. Epub 2016 Jun 16.
BACKGROUND
Over the past decade, patients admitted to addiction treatment programs have reported increasing rates of concurrent opioid and benzodiazepine (BZD) use. This drug combination places individuals at high risk for accidental overdose. Little is known about reasons for BZD use among individuals seeking treatment for opioid use disorders.
METHODS
We surveyed consecutive persons initiating inpatient opioid detoxification and identified 176 out of 438 who reported BZD use in the past 30 days and/or had a positive toxicology.
RESULTS
Forty percent of persons surveyed used a BZD in the month prior to admission, and 25% of these met criteria for BZD dependence (DSM IV). BZD users averaged 32.0 years of age, 63.6% were male, 85.2% used heroin, and reported, on average, 13.3 (±11.2) days of BZD use during the past month. Alprazolam (Xanax) was the most commonly used BZD (52%), and buying it on the street the most common source (48%). The most commonly reported reason for BZD use was 'to manage anxiety' (42.6%), followed by 'to get or enhance a high' (27.7%), 'to help with sleep' (11.4%), and 'to decrease opioid withdrawal' (10.2%). The most common reason for BZD use was significantly associated (p<.001) with most likely source of BZDs, with persons who got their BZDs from a prescriber (23%) more likely to report BZD anxiety as their primary reason for use, while persons who bought BZDs on "the street" (48%) had the highest likelihood of reporting using BZD to get or enhance a high. Participants using BZDs most commonly for anxiety did not endorse lower anxiety than those using BZDs for other reasons.
CONCLUSIONS
Two in five persons seeking detoxification for an opioid use disorder used a BZD in the prior month. Anxiety was the most common reason patients reported using a benzodiazepine, but they also reported using BZDs to enhance a 'high' and manage opioid withdrawal. Evidence-based discussions about the risks of combining BZDs and opioids, and alternatives to BZDs should be a high priority in detoxification settings.
背景
在过去十年中,接受成瘾治疗项目的患者报告称,同时使用阿片类药物和苯二氮䓬类药物(BZD)的比例不断上升。这种药物组合使个体面临意外过量用药的高风险。对于寻求阿片类药物使用障碍治疗的个体中使用BZD的原因,人们了解甚少。
方法
我们对连续入院接受阿片类药物戒毒治疗的患者进行了调查,在438名患者中,确定了176名在过去30天内报告使用过BZD和/或毒理学检测呈阳性的患者。
结果
40%的被调查者在入院前一个月使用过BZD,其中25%符合BZD依赖标准(《精神疾病诊断与统计手册》第四版)。BZD使用者的平均年龄为32.0岁,63.6%为男性,85.2%使用海洛因,并且报告在过去一个月中平均使用BZD 13.3(±11.2)天。阿普唑仑(佳静安定)是最常用的BZD(52%),最常见的获取来源是从街头购买(48%)。报告使用BZD最常见的原因是“缓解焦虑”(42.6%),其次是“获得或增强快感”(27.7%)、“帮助睡眠”(11.4%)和“减轻阿片类药物戒断症状”(10.2%)。使用BZD最常见的原因与BZD最可能的来源显著相关(p<0.001),从开处方者处获得BZD的人(23%)更有可能将缓解焦虑作为使用BZD的主要原因,而在“街头”购买BZD的人(48%)报告使用BZD来获得或增强快感的可能性最高。因焦虑而最常使用BZD的参与者并不比因其他原因使用BZD的参与者报告焦虑程度更低。
结论
五分之二寻求阿片类药物使用障碍戒毒治疗的人在前一个月使用过BZD。焦虑是患者报告使用苯二氮䓬类药物最常见的原因,但他们也报告使用BZD来增强“快感”和控制阿片类药物戒断症状。在戒毒治疗环境中,基于证据讨论BZD与阿片类药物联合使用的风险以及BZD的替代药物应成为高度优先事项。
相似文献
J Subst Abuse Treat. 2016-9
J Subst Abuse Treat. 2017-6
J Psychoactive Drugs. 2017
Nord J Psychiatry. 2010-8
Br J Gen Pract. 2017-7-17
引用本文的文献
Harm Reduct J. 2025-2-27
Exp Clin Psychopharmacol. 2024-6
Front Psychiatry. 2023-1-19
Subst Use Misuse. 2022
本文引用的文献
NCHS Data Brief. 2014-9
J Subst Abuse Treat. 2015-1
N Engl J Med. 2014-5-29
Addict Behav. 2013-5-22
J Subst Abuse Treat. 2012-12-21
Drug Alcohol Depend. 2012-8-2